Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial

被引：0
|
作者：
Isenberg, David [1 ]
Li, Yong [2 ]
Wax, Stephen [3 ]
Wofsy, David [4 ]
Gordon, Caroline [5 ]
机构：
[1] UCL, Ctr Rheumatol, London WC1E 6BT, England
[2] EMD Serono Inc, R&D Global BioStat, Billerica, MA USA
[3] EMD Serono Inc, Global Clin Dev, Rockland, MA USA
[4] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA
[5] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England
来源：
ARTHRITIS RESEARCH & THERAPY | 2014年 / 16卷
关键词：
Systemic Lupus Erythematosus; Vasculitis; Systemic Lupus Erythematosus Patient; Systemic Lupus Erythematosus Disease; Active Systemic Lupus Erythematosus;
D O I：
10.1186/ar4669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A53
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
    David Isenberg
    Yong Li
    Stephen Wax
    David Wofsy
    Caroline Gordon
    [J]. Arthritis Research & Therapy, 16
  • [2] EFFECTS OF ATACICEPT ON DISEASE ACTIVITY IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: APRIL-SLE RANDOMIZED TRIAL
    Gordon, C.
    Isenberg, D.
    Li, Y.
    Wax, S.
    Wofsy, D.
    Rossi, C. Pena
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 77 - 77
  • [3] EFFICACY AND SAFETY OF ATACICEPT FOR PREVENTION OF FLARES IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): 52-WK DATA (APRIL-SLE TRIAL)
    Isenberg, D.
    Gordon, C.
    Licu, D.
    Copt, S.
    Rossi, C. Pena
    Wofsy, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 258 - 259
  • [4] Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
    Isenberg, David
    Gordon, Caroline
    Licu, Daiana
    Copt, Samuel
    Rossi, Claudia Pena
    Wofsy, David
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (11) : 2006 - 2015
  • [5] Trial of atacicept in patients with systemic lupus erythematosus (SLE).
    Dall'Era, Maria
    Chakravarty, Eliza
    Genovese, Mark
    Wallace, Daniel
    Kavanaugh, Arthur
    Kalunian, Kenneth
    Dhar, Patricia
    Pena-Rossi, Claudia
    Wofsy, David
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4042 - 4043
  • [6] PHARMACODYNAMIC EFFECTS OF ATACICEPT IN SLE PATIENTS: 52-WEEK DATA FROM THE APRIL-SLE TRIAL
    Wofsy, D.
    Gordon, C.
    Licu, D.
    Copt, S.
    Rossi, C. Pena
    Isenberg, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 91 - 92
  • [7] Efficacy and Safety Of Atacicept For Prevention Of Flares In Subjects With Moderate To Severe Systemic Lupus Erythematosus (SLE)
    Wofsy, David
    Isenberg, David A.
    Licu, Daiana
    Li, Yong
    Rossi, Claudia Pena
    Gordon, Caroline
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S675 - S675
  • [8] Exploratory Analysis of Pharmacokinetic Effects of Atacicept in Patients with Moderate to Severe Systemic Lupus Erythematosus.
    Wofsy, David
    Gordon, Caroline
    Li, Yong
    Wax, Stephen D.
    Isenberg, David
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1240 - S1241
  • [9] Pharmacodynamics and Predictive Biomarkers In Patients Treated With Atacicept: Data From The APRIL-SLE Trial
    Isenberg, David A.
    Wofsy, David
    Li, Yong
    Licu, Daiana
    Wax, Stephen D.
    Gordon, Caroline
    Rossi, Claudia Pena
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1089 - S1089
  • [10] Effect of Atacicept on Renal Function in Patients with Systemic Lupus Erythematosus (SLE)
    Isenberg, David
    Lin, Celia
    Kao, Amy
    Aydemir, Aida
    Gordon, Caroline
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1980 - 1981
12345